已收盘 09-20 16:00:00 美东时间
-0.100
-1.21%
89Bio Announces Appointment of Teresa Perney, Ph.d. as Chief Regulatory and Qua...
09-17 04:05
89Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
08-10 04:05
89bio (NASDAQ:ETNB) said it has appointed Francis Sarena as COO, effective August 5. Sarena has over two decades of experience, and served as COO and president at Apexigen before joining ETNB. More on...
08-07 20:25
89Bio Appoints Francis Sarena as Chief Operating Officer
08-07 20:00
HC Wainwright & Co. analyst Ed Arce reiterates 89bio (NASDAQ:ETNB) with a Buy and maintains $29 price target.
08-06 18:42
89bio (NASDAQ:ETNB) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.57) by 15.79 percent. This is a 7.69 percent increase over losses of $(0.52) per share from the same
08-06 04:34
89Bio Q2 Net Income USD -47.971 Million Vs. IBES Estimate USD -56.1 Million
08-06 04:05
89Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
06-15 04:05
针对肝脏疾病非酒精性脂肪性肝炎(NASH)的药物开发商的股价在周三普遍下挫,原因是早前礼来减肥药物替西帕肽的中期试验详细数据显示了其治疗NASH的潜力。
06-05 21:34
Developers of drugs targeting a liver disease called nonalcoholic steatohepatitis (NASH) trended lower in the premarket on Wednesday after detailed data from a mid-stage trial for Eli Lilly's (NYSE:LL...
06-05 20:10